Application 078791
- Type
- ANDA
- Sponsor
- IMPAX LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIVALPROEX SODIUM | DIVALPROEX SODIUM | TABLET, EXTENDED RELEASE;ORAL | EQ 250MG VALPROIC ACID | No | No |
| 002 | DIVALPROEX SODIUM | DIVALPROEX SODIUM | TABLET, EXTENDED RELEASE;ORAL | EQ 500MG VALPROIC ACID | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0115-6911 | Divalproex Sodium | DIVALPROEX SODIUM | Impax Generics | ANDA | Current |
| 0115-6911 | Divalproex Sodium | DIVALPROEX SODIUM | Impax Generics | ANDA | Current |
| 0115-6922 | Divalproex Sodium | DIVALPROEX SODIUM | Impax Generics | ANDA | Current |
| 0115-6922 | Divalproex Sodium | DIVALPROEX SODIUM | Impax Generics | ANDA | Current |
| 67296-1635 | Divalproex Sodium | DIVALPROEX SODIUM | RedPharm Drug, Inc. | ANDA | Current |
| 67296-1635 | Divalproex Sodium | DIVALPROEX SODIUM | RedPharm Drug, Inc. | ANDA | Current |
| 71610-201 | Divalproex Sodium | DIVALPROEX SODIUM | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |